SearcharxivSearch

arXiv · 2510.23833

On the distributions of restriction sites in human and pangolin sarbecoviruses

Abstract

Since early 2020, several theories have suggested that a distribution of restriction endonuclease recognition sites in the SARS-CoV-2 genome indicates a synthetic origin. The most influential of these, a 2022 preprint by Bruttel et al. claimed: "The BsaI/BsmBI restriction map of SARS-CoV-2 is unlike any wild-type coronavirus, and it is unlikely to evolve from its closest relatives." To test this, I reanalyzed the same 11 contested sites using an expanded set of sarbecovirus genomes, including bat coronaviruses published after the Bruttel et al. preprint. For each site, I identified the bat coronaviruses most closely matching SARS-CoV-2 in the surrounding sequences, excluding the sites themselves. The Bruttel et al. hypothesis predicts that these closely related viruses should differ from SARS-CoV-2 at many of the contested sites if restriction sites had been artificially introduced or removed. Contrary to this prediction, one or more of the most closely related bat coronaviruses are identical to SARS-CoV-2 at all 11 sites. Equivalent "synthetic fingerprints" were identified in natural pangolin sarbecoviruses. Finally, I conducted a re-analysis of the dataset that Bruttel et al. used to test where the SARS-CoV-2 BsaI/BsmBI restriction map was significantly more "evenly spaced" than expected in a natural genome. I found technical and conceptual errors that resulted in Bruttel et al. reporting that their chosen metric was 0.07% likely to occur by chance rather than 4.2%, reducing the apparent rarity 60-fold. Using a more informative metric, I tested whether restriction sites in SARS-CoV-2 or two pangolin sarbecoviruses were significantly more evenly spaced than expected and found they were not. These results show that the restriction maps of SARS-CoV-2 and related pangolin viruses are unremarkable in the context of related bat coronaviruses.

Explore related subjects

Keep this discovery

BibTeXRIS

Zach Hensel. 2025-10-27. On the distributions of restriction sites in human and pangolin sarbecoviruses. https://arxiv.org/abs/2510.23833

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

MarkerScout: A Disease-Agnostic Machine Learning Framework for Biomarker Prediction from Multi-Scale Mechanistic Models

We demonstrate the framework on three infectious diseases derived from a companion mechanistic immune-simulation platform: SARS-CoV-2, Influenza A Virus, and Plasmodium falciparum. Each disease was evaluated across hospitalization and intensive care unit cohorts, yielding six cohorts in total. Best-pipeline cross-validated macro F1 ranged from 0.82 for IAV-HOSP to 0.99 for COV-ICU, and the framework produced tiered, direction-aware biomarker lists for each disease and phase. Interleukin-18 (IL-18) reached the strongest tier in both SARS-CoV-2 phases with consistent direction. When benchmarked against three separate, independently collected clinical ICU datasets, MarkerScout's top-ranked features outperformed 94.4% of randomly selected feature sets of equivalent size for SARS-CoV-2, with a weaker but directionally consistent advantage for Influenza A Virus (66.7%) and Plasmodium falciparum (60.7%).

q-bio.OT

Enhancing Clinical Decision Support and Differential Diagnosis with Knowledge Graphs, and Retrieval Augmented Generation in Generative AI

Diagnostic error carries a burden, while unconstrained large language models (LLMs) remain vulnerable to hallucination and weak integration of quantitative laboratory dynamics. We developed a decision-support pipeline combining disease-specific biomarker correlation graphs, ordinary differential equations (ODEs), deep sequence classification, and retrieval-augmented generation (RAG). For 103 disease classes from a full blood count (FBC) repository, biomarker networks were used as coupling matrices to generate 30 trajectories per disease (3,090 total). A one-dimensional convolutional neural network (CNN) and long short-term memory (LSTM) network classified disease trajectories and six dynamical clusters. A constrained GPT-4o-mini RAG layer used a 19-pattern BMJ Best Practice/NICE corpus to generate differential diagnoses evaluated for diagnostic suitability, evidential grounding, and clinical plausibility. Across five random-seed runs, disease-level accuracy was $0.940 \pm 0.006$ for the CNN (95\% CI 0.933--0.948) and $0.852 \pm 0.019$ for the LSTM (95\% CI 0.828--0.875); the CNN advantage was 8.87 percentage points (95\% CI 6.47--11.27; $t(4)=10.26$, $p=5.1\times10^{-4}$; Hedges' $g=3.67$). Among 100 sampled RAG cases, 96 parsed successfully; evidence was cited in 97.9\%, the true diagnosis was mentioned in 71.9\%, and the composite score was 3.82/5 with a 47.9\% strict pass rate. The central finding was a decoupling between grounding and diagnostic correctness: classifier-correct versus classifier-wrong outputs differed in diagnostic suitability but not evidential grounding. Post-hoc analysis confirmed a 1.02-point diagnostic-score difference (Mann--Whitney $p=0.0024$; Hedges' $g=0.72$), whereas grounding differed by only $-0.02$ points ($p=0.839$; $g=-0.04$).

q-bio.OT

Expanding the Human Ancestry Ontology to include under-represented populations and ethnicities for broader utility in annotations

Successful discovery, integration and reuse of data relies on the availability of rich, well-structured and machine-readable metadata to describe every aspect of the data, from sample sources to collection processes to experimental protocols. The use of standardised terminologies to express concepts in a harmonised fashion lies at the core of high-quality data annotation, increasing the FAIRness of the data, facilitating data integration and promoting reproducibility. Here, we describe the Human Ancestry Ontology (HANCESTRO), originally developed to improve standardised reporting of genetic ancestry genomic resources such as the NHGRI-EBI GWAS Catalog and the Human Cell Atlas through high-level population descriptors, and more recently expanded to include diverse and previously under-represented populations in genomics and genetics research. HANCESTRO provides a framework for population descriptors that includes both ancestry based on the analysis of genetic information and self-reported ethnicity, which is based on social and cultural factors that don't necessarily align with genetic populations. By enabling the accurate and interoperable representation of population-related data, it promotes inclusive, representative and reproducible science.

q-bio.OT